We found patients with ITPA genotype rs1127354-CC are significantly at higher risk of developing ribavirin-associated anemia as compared to patients with a non-CC genotype that leads to less adherence to ribavirin dose but no statistically significant impact of ITPA genotype has been found on SVR achievement. This evidence concerns the gene ITPA and anemia (phenotype).